OraLiva awarded $1.9M National Institute of Dental and Craniofacial Research (NIDCR at NIH) Direct to Phase II SBIR grant for AI-linked cytomics-on-a-chip
The Future
of Cancer Diagnostics
OraLiva empowers dental providers with pathology-level accuracy—using a simple, non-invasive brush test backed by clinical validation.
